サマリー

米国の医療技術管理市場は、予測期間中の年平均成長率15.6%で、2023年の84億米ドルから2028年には173億米ドルに達すると予測されている。この市場の成長を牽引しているのは、ISOが提供するメリットやデータセキュリティに対するニーズの高まりといった要因である。同時に、熟練した技術者や臨床/生物医学エンジニアの不足が市場の抑制要因になる可能性もある。マルチベンダー契約への嗜好の高まりは、今後数年間の市場の課題となる可能性がある。

「予測期間中、保守・修理分野が最も高い成長率を示すだろう。
医療技術管理市場は、サービスの種類に基づき、資本計画、サイバーセキュリティ、統合ソフトウェアプラットフォーム、労務管理、保守・修理、サプライチェーン（調達）、品質・規制コンプライアンスに区分される。2022年には、保守・修理分野が市場で最大のシェアを獲得した。この市場の成長に影響を与える要因としては、さまざまな医療施設における高度な医療機器や消耗品の使用の増加、患者の安全性向上の必要性、画像システムの使用を促進する政府の取り組みなどが挙げられる。

"急性期医療施設セグメントが2020年の米国医療技術管理市場で最大のシェアを占めると推定される"
施設タイプに基づき、米国の医療技術管理市場はポストアキュートケア施設、急性期ケア施設、非急性期ケア施設に区分される。急性期施設は最も高いCAGRで成長し、2022年の米国医療技術管理市場で最大のシェアを占めると予想される。急性期医療施設セグメントの市場シェアが大きく、成長率も高いのは、患者数の全体的な増加、より良い臨床資産管理の需要、患者ケア基準の強化の必要性などの要因が大きく、これらすべてが医療技術管理サービスの需要を押し上げているためである。

供給側一次面接の企業タイプ別、呼称別、地域別内訳
- 企業タイプ別ティア1 (33%)、ティア2 (39%)、ティア3 (28%)
- 役職別Cレベル(44%)、Dレベル(35%)、その他(21%)

米国の医療技術管理市場で事業を展開している主要企業は、GEヘルスケア（米国）、TRIMEDX（米国）、シーメンス・ヘルティニアーズ（ドイツ）、Koninklijke Philips N.V.（オランダ）、Sodexo（フランス）、Crothall Healthcare（米国）、Agility Inc（米国）、RENOVO Solutions（米国）、ABM Industries Incorporated（米国）、JANNX Medical System（米国）、InterMed Group（米国）である。

調査範囲
この調査レポートは、米国の医療技術管理市場を様々なセグメントにわたって調査しています。サービスタイプ別、施設タイプ別など、さまざまなセグメントにわたる市場規模や成長可能性を推定することを目的としています。また、市場主要企業の詳細な競合分析、企業プロフィール、サービスや事業内容、最近の動向、主要市場戦略などに関する主要な見解を掲載しています。

レポート購入の主なメリット

本レポートは、米国の医療技術管理市場全体とサブセグメントにおける収益数の最も近い概算に関する情報を提供し、同市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、当レポートは関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
米国医療技術管理市場の成長に影響を与える主な促進要因（病院におけるより良い資産管理の必要性、ISOが提供する利点、予防的医療機器メンテナンスへの注目の高まり、データセキュリティへのニーズの高まり）、阻害要因（熟練技術者や臨床/生物医学エンジニアの不足）、機会（米国医療業界における統合の増加）、課題（複数ベンダー契約の選好）の分析
- 市場への浸透：米国医療技術管理市場のトップ企業が提供するサービスポートフォリオに関する包括的情報。本レポートでは、この市場をサービスタイプ別、施設タイプ別に分析しています。
- サービスの強化/革新：米国医療技術管理市場における今後の動向とサービス開始に関する詳細な洞察。
- 市場開発：サービスタイプ別、施設タイプ別の有利な新興市場に関する包括的情報。
- 市場の多様化：米国の医療技術管理市場における新サービス、成長地域、最新動向、投資に関する詳細情報。
- 競合評価：米国医療技術管理市場における主要企業の市場シェア、成長戦略、サービス提供、能力を詳細に評価します。

ページTOPに戻る

目次

1 INTRODUCTION 16
1.1 STUDY OBJECTIVES 16
1.2 MARKET DEFINITION 17
TABLE 1 SERVICE TYPE 17
TABLE 2 INCLUSIONS AND EXCLUSIONS 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED 19
1.4 CURRENCY CONSIDERED 19
TABLE 3 STANDARD CURRENCY CONVERSION RATES 19
1.5 STAKEHOLDERS 20
1.6 SUMMARY OF CHANGES 20
1.6.1 RECESSION IMPACT 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
FIGURE 1 RESEARCH DESIGN 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY RESEARCH 24
FIGURE 2 PRIMARY SOURCES 25
2.1.2.1 Key data from primary sources 26
2.1.2.2 Breakdown of primary interviews 26
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE AND DESIGNATION 26
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY FACILITY TYPE AND DESIGNATION 27
2.2 MARKET SIZE ESTIMATION METHODOLOGY 27
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 28
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022) 28
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 29
FIGURE 7 TOP-DOWN APPROACH 30
FIGURE 8 BOTTOM UP APPROACH 30
2.2.2 GROWTH FORECAST 31
FIGURE 9 US HEALTHCARE TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 31
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 32
2.2.3 PRIMARY RESEARCH VALIDATION 32
FIGURE 11 KEY INSIGHTS FROM PRIMARY EXPERTS 33
 
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 34
FIGURE 12 DATA TRIANGULATION METHODOLOGY 34
2.4 MARKET RANK ESTIMATION 35
2.5 STUDY ASSUMPTIONS 35
2.6 RISK ASSESSMENT 36
TABLE 4 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: RISK ASSESSMENT ANALYSIS 36
2.7 RESEARCH LIMITATIONS 36
2.8 RECESSION IMPACT ANALYSIS 36
3 EXECUTIVE SUMMARY 37
FIGURE 13 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION) 37
FIGURE 14 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY FACILITY TYPE, 2023 VS. 2028 (USD MILLION) 38
4 PREMIUM INSIGHTS 39
4.1 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET OVERVIEW 39
FIGURE 15 INCREASING NEED FOR CLINICAL ASSET MANAGEMENT TO DRIVE MARKET 39
4.2 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY FACILITY TYPE 40
FIGURE 16 ACUTE CARE FACILITIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 40
4.3 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY SERVICE TYPE AND FACILITY TYPE 41
FIGURE 17 MAINTENANCE & REPAIR SERVICES SEGMENT IN ACUTE CARE FACILITIES ACCOUNTED FOR LARGEST MARKET SHARE FOR 2022 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 18 HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing need for clinical asset management in hospitals 43
5.2.1.2 Advantages offered by ISOs 43
5.2.1.3 Growing focus on preventive medical equipment maintenance 44
5.2.1.4 Rising need to curb cybersecurity risks 44
5.2.2 RESTRAINTS 44
5.2.2.1 Shortage of skilled technicians 44
5.2.3 OPPORTUNITIES 45
5.2.3.1 Expansion of healthcare facilities 45
5.2.4 CHALLENGES 45
5.2.4.1 Preference for multi-vendor contracts 45
 
5.3 INDUSTRY TRENDS 46
5.3.1 CLOUD-BASED IT SOLUTIONS 46
5.4 REGULATORY ANALYSIS 46
5.4.1 ISO STANDARDS 46
5.4.1.1 ISO 9001:2015 46
5.4.1.2 ISO 13485:2016 47
5.4.2 US 47
5.5 VALUE CHAIN ANALYSIS 48
FIGURE 19 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 48
5.6 SUPPLY CHAIN ANALYSIS 48
FIGURE 20 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: SUPPLY CHAIN ANALYSIS 49
5.7 ECOSYSTEM MAPPING 50
FIGURE 21 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: ECOSYSTEM MAP 50
5.8 PORTER'S FIVE FORCES ANALYSIS 50
TABLE 5 PORTER’S FIVE FORCES ANALYSIS 51
5.8.1 THREAT OF NEW ENTRANTS 51
5.8.2 THREAT OF SUBSTITUTES 51
5.8.3 BARGAINING POWER OF SUPPLIERS 51
5.8.4 BARGAINING POWER OF BUYERS 52
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 52
5.9 PATENT ANALYSIS 52
5.9.1 PATENT PUBLICATION TRENDS 52
FIGURE 22 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: US PATENT PUBLICATION TRENDS (2015–2023) 53
5.9.2 TOP PATENT APPLICANTS 53
FIGURE 23 TOP APPLICANTS FOR US HEALTHCARE TECHNOLOGY MANAGEMENT PATENTS (2015–2023) 53
5.10 TECHNOLOGY ANALYSIS 54
5.10.1 MACHINE LEARNING 54
5.10.2 ARTIFICIAL INTELLIGENCE 54
5.10.3 INTERNET OF THINGS 54
5.10.4 BLOCKCHAIN 54
5.10.5 BIG DATA 54
5.11 PRICING ANALYSIS 55
TABLE 6 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: AVERAGE SELLING PRICE OF SERVICES OFFERED BY KEY PLAYERS 55
5.12 KEY CONFERENCES AND EVENTS 56
5.12.1 US HEALTHCARE TECHNOLOGY MARKET: KEY CONFERENCES AND EVENTS (2023−2024) 56
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 56
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 56
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SERVICE TYPE 56
5.13.2 KEY STAKEHOLDERS IN BUYING CRITERIA 57
FIGURE 25 KEY BUYING CRITERIA FOR HEALTHCARE TECHNOLOGY MANAGEMENT SERVICES 57
TABLE 7 US HEALTHCARE TECHNOLOGY MANAGEMENT: BUYING CRITERIA FOR SERVICE TYPE 57
6 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY SERVICE TYPE 58
6.1 INTRODUCTION 59
TABLE 8 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 59
6.2 MAINTENANCE & REPAIR SERVICES 60
6.2.1 RECURRING REQUIREMENT FOR PREVENTIVE MAINTENANCE TO DRIVE MARKET 60
6.3 CAPITAL PLANNING SERVICES 60
6.3.1 RISING NEED FOR CAPITAL BUDGETING AND INVENTORY ANALYTICS TO PROPEL MARKET 60
6.4 INTEGRATED SOFTWARE PLATFORM 61
6.4.1 SIMPLIFICATION OF HEALTHCARE ASSETS DUE TO INCLUSION OF CMMS TO DRIVE MARKET 61
6.5 QUALITY & REGULATORY COMPLIANCE 61
6.5.1 STRINGENT REGULATORY COMPLIANCE FOR HEALTHCARE INDUSTRY TO FUEL MARKET 61
6.6 LABOR MANAGEMENT 62
6.6.1 PROVISION OF STREAMLINED OPERATIONS FOR OPTIMAL PRODUCTIVITY TO SUPPORT MARKET GROWTH 62
6.7 SUPPLY CHAIN SERVICES 62
6.7.1 ABILITY TO TRACK EQUIPMENT IN REAL-TIME TO FUEL MARKET 62
6.8 CYBERSECURITY SERVICES 63
6.8.1 RISING NEED TO MITIGATE DATA SECURITY RISKS TO DRIVE MARKET 63
7 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY FACILITY TYPE 64
7.1 INTRODUCTION 65
TABLE 9 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET, BY FACILITY TYPE, 2021–2028 (USD MILLION) 65
7.2 ACUTE CARE FACILITIES 65
TABLE 10 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET FOR ACUTE CARE FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 66
7.2.1 ACUTE HOSPITALS 66
7.2.1.1 Rising patient volume due to increasing incidence of chronic diseases to drive market 66
7.2.2 PEDIATRIC HOSPITALS 67
7.2.2.1 Increasing efforts to improve child care to propel market 67
7.2.3 ACADEMIC MEDICAL CENTERS 67
7.2.3.1 Advanced research facilities equipped for student training to propel market 67
 
7.2.4 MILITARY TREATMENT FACILITIES 67
7.2.4.1 Federal government initiatives for quality care to drive market 67
7.2.5 AMBULATORY SURGERY CENTERS 68
7.2.5.1 Low costs and convenience offered by ASCs to propel market 68
7.3 POST-ACUTE CARE FACILITIES 68
TABLE 11 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET FOR POST-ACUTE CARE FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 69
7.3.1 LONG-TERM ACUTE CARE FACILITIES 69
7.3.1.1 Provision of specialized care for senior individuals to drive market 69
7.3.2 SKILLED NURSING FACILITIES 70
7.3.2.1 Patient requirement for long-term therapeutic care to support market growth 70
7.3.3 OTHER POST-ACUTE CARE FACILITIES 70
7.4 NON-ACUTE CARE FACILITIES 70
TABLE 12 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET FOR NON-ACUTE CARE FACILITIES, BY TYPE, 2021–2028 (USD MILLION) 71
7.4.1 CLINICS 71
7.4.1.1 Growing adoption of digitized workflows to propel market 71
7.4.2 OTHER NON-ACUTE CARE FACILITIES 71
8 COMPETITIVE LANDSCAPE 72
8.1 OVERVIEW 72
8.2 STRATEGIES ADOPTED BY KEY PLAYERS 72
8.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 73
FIGURE 26 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS (2018−2022) 73
8.4 R&D EXPENDITURE OF KEY PLAYERS 74
FIGURE 27 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: R&D EXPENDITURE OF KEY PLAYERS (2021 VS. 2022) 74
8.5 MARKET RANKING 74
FIGURE 28 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: RANKING FOR MULTI-VENDOR OEMS (2022) 74
FIGURE 29 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: RANKING ANALYSIS FOR ISOS (2022) 75
8.6 COMPANY EVALUATION MATRIX 75
8.6.1 STARS 76
8.6.2 EMERGING LEADERS 76
8.6.3 PERVASIVE PLAYERS 76
8.6.4 PARTICIPANTS 76
FIGURE 30 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (2022) 77
 
8.7 COMPETITIVE BENCHMARKING 78
TABLE 13 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: SERVICE TYPE PORTFOLIO ANALYSIS 78
TABLE 14 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: FACILITY TYPE PORTFOLIO ANALYSIS 79
TABLE 15 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: COMPANY PORTFOLIO ANALYSIS 80
8.8 COMPETITIVE SITUATIONS AND TRENDS 81
8.8.1 SERVICE LAUNCHES 81
TABLE 16 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: SERVICE LAUNCHES (JANUARY 2020–JULY 2023) 81
8.8.2 DEALS 82
TABLE 17 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: DEALS (JANUARY 2020–JULY 2023) 82
8.8.3 OTHER DEVELOPMENTS 84
TABLE 18 US HEALTHCARE TECHNOLOGY MANAGEMENT MARKET: OTHER DEVELOPMENTS (JANUARY 2020–JULY 2023) 84
9 COMPANY PROFILES 85
9.1 KEY PLAYERS 85
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1.1 GE HEALTHCARE 85
TABLE 19 GE HEALTHCARE: BUSINESS OVERVIEW 85
FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 86
9.1.2 SIEMENS HEALTHINEERS 88
TABLE 20 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 88
FIGURE 32 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022) 89
9.1.3 KONINKLIJKE PHILIPS N.V. 92
TABLE 21 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 92
FIGURE 33 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 93
9.1.4 TRIMEDX 95
TABLE 22 TRIMEDX: BUSINESS OVERVIEW 95
9.1.5 AGILITI, INC. 97
TABLE 23 AGILITI, INC.: BUSINESS OVERVIEW 97
FIGURE 34 AGILITI, INC.: COMPANY SNAPSHOT (2022) 97
9.1.6 CROTHALL HEALTHCARE (SUBSIDIARY OF COMPASS GROUP) 99
TABLE 24 CROTHALL HEALTHCARE: BUSINESS OVERVIEW 99
FIGURE 35 COMPASS GROUP: COMPANY SNAPSHOT (2022) 100
9.1.7 SODEXO 103
TABLE 25 SODEXO: BUSINESS OVERVIEW 103
FIGURE 36 SODEXO: COMPANY SNAPSHOT (2022) 104
9.1.8 ABM INDUSTRIES INCORPORATED 106
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 106
FIGURE 37 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2022) 107
9.1.9 RENOVO SOLUTIONS 108
TABLE 27 RENOVO SOLUTIONS: BUSINESS OVERVIEW 108
9.1.10 INTERMED GROUP, INC. 110
TABLE 28 INTERMED GROUP, INC.: BUSINESS OVERVIEW 110
9.1.11 JANNX MEDICAL SYSTEMS 112
TABLE 29 JANNX MEDICAL SYSTEMS: BUSINESS OVERVIEW 112
9.1.12 ORACLE 113
TABLE 30 ORACLE: COMPANY OVERVIEW 113
FIGURE 38 ORACLE: COMPANY SNAPSHOT (2022) 114
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 116
10.1 DISCUSSION GUIDE 116
10.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 119
10.3 CUSTOMIZATION OPTIONS 121
10.4 RELATED REPORTS 121
10.5 AUTHOR DETAILS 122